7th Eurasian Hematology Oncology Summit
2020 Updates on CAR-T in R/R MM: What Is the Incidence of AEs With bb2121? Does Idecabtagene Vicleucel Improve ORR? Is Orvacabtagene Autoleucel Safe and Tolerable?
By
7th Eurasian Hematology Oncology Summit
FEATURING
Evangelos Terpos
By
7th Eurasian Hematology Oncology Summit
FEATURING
Evangelos Terpos
Login to view comments.
Click here to Login